Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: Type i deficiency as a strong risk factor for venous thromboembolism

International Journal of Hematology

Volumn 92, Issue 3, 2010, Pages 468-473

  Mitsuguro, Mana ^a   Sakata, Toshiyuki ^a   Okamoto, Akira ^a   Kameda, Sachika ^a   Kokubo, Yoshihiro ^a   Tsutsumi, Yoshiaki ^a   Sano, Michitaka ^a   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Antithrombin deficiency; Deep vein thrombosis; Phenotype; Risk assessment; Venous thromboembolism

Indexed keywords

ANTITHROMBIN;

ADULT; AGED; ANTITHROMBIN DEFICIENCY; ANTITHROMBIN DEFICIENCY TYPE 1; ANTITHROMBIN DEFICIENCY TYPE 2; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; HOSPITAL PATIENT; HUMAN; JAPANESE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PHENOTYPIC VARIATION; POPULATION DISTRIBUTION; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III DEFICIENCY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 78549236460     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0687-5     Document Type: Article

References (26)

1. V De Stefano G Finazzi PM Mannucci 1996 Inherited thrombophilia: pathogenesis, clinical syndromes, and management Blood 87 3531 3544 8611675
2. DJ Perry RW Carrell 1996 Molecular genetics of human antithrombin deficiency Hum Mutat 7 7 22 1:CAS:528:DyaK28XosFWkuw%3D%3D 10.1002/(SICI)1098- 1004(1996)7:1<7::AID-HUMU2>3.0.CO;2-B 8664906 (Pubitemid 26002082)
3. DA Lane PM Mannucci KA Bauer RM Bertina NP Bochkov V Boulyjenkov, et al. 1996 Inherited thrombophilia: Part 1 Thromb Haemost 76 651 662 1:CAS:528:DyaK28XntFSjtrk%3D 8950768
4. O Egeberg 1965 Inherited antithrombin deficiency causing thrombophilia Thromb Diath Haemorrh 13 516 530 1:STN:280:DyaF2M7lt1Oqsg%3D%3D 14347873
5. DA Lane T Bayston RJ Olds AC Fitches DN Cooper DS Millar, et al. 1997 Antithrombin mutation database: 2nd (1997) update for the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thromb Haemost 77 197 211 1:CAS:528:DyaK2sXhtFSktbk%3D 9031473
6. T Miyata Y Sato J Ishikawa H Okada S Takeshita T Sakata, et al. 2009 Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis Thromb Res 124 14 18 1:CAS:528:DC%2BD1MXltFWnt7o%3D 10.1016/j.thromres.2008.08.020 18954896
7. T Koster FR Rosendaal E Briet FJ van der Meer LP Colly PH Trienekens, et al. 1995 Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) Blood 85 2756 2761 1:CAS:528:DyaK2MXls1Sru7Y%3D 7742536
8. BJ Sanson P Simioni D Tormene M Moia PW Friederich MV Huisman, et al. 1999 The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study Blood 94 3702 3706 1:CAS:528:DyaK1MXnslykt7Y%3D 10572082
9. T Sakata A Okamoto T Mannami H Matsuo T Miyata 2004 Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese J Thromb Haemost 2 528 530 1:CAS:528:DC%2BD2cXktVGmsLk%3D 10.1111/j.1538-7836.2004.00603.x 15009480 (Pubitemid 40185670)
10. CY Vossen ID Walker P Svensson JC Souto I Scharrer FE Preston, et al. 2005 Recurrence rate after a first venous thrombosis in patients with familial thrombophilia Arterioscler Thromb Vasc Biol 25 1992 1997 1:CAS:528: DC%2BD2MXos1ektLo%3D 10.1161/01.ATV.0000174806.76629.7b 15976329 (Pubitemid 41243474)
11. CY Vossen J Conard J Fontcuberta M Makris FJ VDM I Pabinger, et al. 2005 Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT) J Thromb Haemost 3 459 464 1:STN:280:DC%2BD2M7hvFGruw%3D%3D 10.1111/j.1538-7836.2005. 01197.x 15748234 (Pubitemid 41632870)
12. WM Lijfering JL Brouwer NJ Veeger I Bank M Coppens S Middeldorp, et al. 2009 Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives Blood 113 5314 5322 1:CAS:528:DC%2BD1MXmslaksr8%3D 10.1182/blood-2008-10-184879 19139080
13. RC Tait ID Walker DJ Perry SI Islam ME Daly F McCall, et al. 1994 Prevalence of antithrombin deficiency in the healthy population Br J Haematol 87 106 112 1:STN:280:DyaK2M%2FjsVajtA%3D%3D 10.1111/j.1365-2141.1994.tb04878.x 7947234
14. PS Wells MA Blajchman P Henderson MJ Wells C Demers R Bourque, et al. 1994 Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study Am J Hematol 45 321 324 1:STN:280:DyaK2c3jsVWhsQ%3D%3D 10.1002/ajh.2830450409 8178802
15. G Finazzi R Caccia T Barbui 1987 Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases Thromb Haemost 58 1094 1:STN:280:DyaL1c7nvVGmtg%3D%3D 3328320
16. J Hirsh F Piovella M Pini 1989 Congenital antithrombin III deficiency. Incidence and clinical features Am J Med 87 34S 38S 1:STN:280: DyaK3c%2FitlGisQ%3D%3D 10.1016/0002-9343(89)80529-7 2679068
17. C Demers JS Ginsberg J Hirsh P Henderson MA Blajchman 1992 Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review Ann Intern Med 116 754 761 1:STN:280:DyaK383hsVyksQ%3D%3D 1489375
18. T Koide S Odani K Takahashi T Ono N Sakuragawa 1984 Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability Proc Natl Acad Sci USA 81 289 293 1:CAS:528:DyaL2cXhslamu70%3D 10.1073/pnas.81.2.289 6582486
19. A Okamoto T Sakata T Mannami S Baba Y Katayama H Matsuo, et al. 2003 Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in the Japanese: the Suita study J Thromb Haemost 1 2397 2403 1:CAS:528:DC%2BD2cXktFGrs7w%3D 10.1046/j.1538-7836.2003.00419.x 14629475
20. T Miyata R Kimura Y Kokubo T Sakata 2006 Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation Int J Hematol 83 217 223 1:CAS:528:DC%2BD28XltFeqsLc%3D 10.1532/IJH97.A20514 16720551 (Pubitemid 44227996)
21. Y Kokubo S Nakamura T Okamura Y Yoshimasa H Makino M Watanabe, et al. 2009 Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita study Stroke 40 2674 2679 10.1161/STROKEAHA.109.550707 19478215
22. Y Kokubo K Kamide T Okamura M Watanabe A Higashiyama K Kawanishi, et al. 2008 Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study Hypertension 52 652 659 1:CAS:528:DC%2BD1cXhtV2jsrrN 10.1161/HYPERTENSIONAHA.108.118273 18725580
23. H Ueyama T Murakami S Nishiguchi S Maeda Y Hashimoto K Okajima, et al. 1990 Antithrombin III Kumamoto: identification of a point mutation and genotype analysis of the family Thromb Haemost 63 231 234 1:CAS:528:DyaK3MXkt1ah 2194315
24. K Shimizu F Toriyama F Ogawa I Katayama K Okajima 2001 Recurrent leg ulcers and arterial thrombosis in a 33-year-old homozygous variant of antithrombin Am J Hematol 66 285 291 1:STN:280:DC%2BD3M7ovV2lsA%3D%3D 10.1002/ajh.1059 11279641 (Pubitemid 32210298)
25. K Okajima H Abe M Wagatsuma H Okabe K Takatsuki 1995 Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin Am J Hematol 48 12 18 1:CAS:528:DyaK2MXks1SmtLo%3D 10.1002/ajh.2830480104 7832187
26. K Nagaizumi H Inaba K Amano M Suzuki M Arai K Fukutake 2003 Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis Int J Hematol 78 79 83 1:CAS:528:DC%2BD3sXmsl2rur4%3D 10.1007/BF02983246 12894857